Cancer Treatment Reviews
Volume 27, Issue 1 , Pages 1-7, February 2001

Pregnancy and radiation

  • E. Fenig

      Affiliations

    • Institute of Oncology, Rabin Medical Center, Beilinson Campus, Petah Tiqva and 
  • ,
  • M. Mishaeli

      Affiliations

    • Institute of Oncology, Rabin Medical Center, Beilinson Campus, Petah Tiqva and 
  • ,
  • Y. Kalish

      Affiliations

    • Institute of Oncology, Rabin Medical Center, Beilinson Campus, Petah Tiqva and 
  • ,
  • M. Lishner

      Affiliations

    • Department of Medicine A, Sapir Medical Center, Kfar Sava and Sackler Faculty of Medicine,Tel Aviv University, Tel Aviv, Israel

Abstract 

The risk of foetal irradiation during pregnancy is discussed. It seems that, due to the low level of X-ray exposure to the foetus, neither diagnostic radiography nor nuclear diagnostic examination justifies termination of pregnancy. Radiotherapy for breast cancer, Hodgkin’s disease and cervical cancer in pregnant women is reviewed.

Radiation therapy for breast cancer is not an absolute contraindication for pregnancy and the risk–benefit assessment should be discussed with the mother. The risk to the foetus duning radiotherapy for supradiaphragmatic Hodgkin’s disease appears to be minimal, provided special attention is paid to the treatment techniques and the foetus is adequately shielded. Radiotherapy for the treatment of cervical cancer may be necessary during pregnancy, but the timing should be adjusted taking into consideration gestational age.

Offspring of cancer patients who were treated by radiotherapy appear to be at little risk of childhood cancer or birth defects. Cancer patients should not be discouraged from having children and can expect a good outcome of pregnancy. However, in the non-pregnant woman, to further reduce any risk it is advisable to delay pregnancy for 12 months following completion of radiation therapy.

Keywords: Radiation,  X-ray, breast cancer, Hodgkin’s disease, cervical cancer.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(00)90193-2

doi:10.1053/ctrv.2000.0193

Cancer Treatment Reviews
Volume 27, Issue 1 , Pages 1-7, February 2001